Showing results (181-190 of 435) with videos related to

Sort By:
Pageof 44
EJNMMI Radiopharmacy and Chemistry|September 10, 2024
GMP-compliant automated radiosynthesis of [18F] SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2 A (SV2A)Lijuan Chen, Xiaochen Li, Yao Ge, et al.
EJNMMI Radiopharmacy and Chemistry|August 24, 2024
Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancerJubilee Andrew, Amanda-Lee Ezra-Manicum, Bwalya Angel Witika
EJNMMI Radiopharmacy and Chemistry|November 21, 2024
Numerical simulation method for the assessment of the effect of molar activity on the pharmacokinetics of radioligands in small animalsTatsuya Kikuchi, Toshimitsu Okamura, Ming-Rong Zhang
EJNMMI Radiopharmacy and Chemistry|October 29, 2024
Design and development of nanoprobes radiolabelled with 99mTc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical researchMaría Jimena Salgueiro, Mariano Portillo, Fiorella Tesán, et al.
EJNMMI Radiopharmacy and Chemistry|November 13, 2024
Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapyChiara Timperanza, Anna Gustafsson-Lutz, Tom Bäck, et al.
EJNMMI Radiopharmacy and Chemistry|July 24, 2024
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancerHerlinde Dierick, Laurent Navarro, Hannelore Ceuppens, et al.
EJNMMI Radiopharmacy and Chemistry|June 17, 2024
In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structureHiroyuki Suzuki, Kento Kannaka, Mizuki Hirayama, et al.
EJNMMI Radiopharmacy and Chemistry|November 6, 2023
Evaluation of the 177mLu-concentration in in-house produced 177Lu-radiopharmaceuticals and commercially available Lutathera®Matthias Balzer, Fleur Spiecker, Stephanie Bluemel, et al.
EJNMMI Radiopharmacy and Chemistry|October 19, 2023
TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studiesJulien Leenhardt, Alexandre Biguet Petit Jean, Florian Raes, et al.
EJNMMI Radiopharmacy and Chemistry|April 15, 2024
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trialSadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, et al.
Pageof 44